Study/chemical-biological
Ended Awarded
- Contract number
- HHSN26100002
- Awardee
-
Myriad Genetic Laboratories Inc. UEI H7C7T3D6ZSB8 Part of Myriad Genetics Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $30,000
Award facts
- Contract value 100% obligated
- $30,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Emigration Canyon, UT 84108, USA
- Legislative mandates
-
- Other statutory authority
Award details come from SAM.gov/FPDS.
About this award
Myriad Genetic Laboratories Inc., a subsidiary of Myriad Genetics Inc., was awarded a delivery order valued at $30,000 by the National Cancer Institute on June 25, 2007, with a completion date of September 20, 2007. This firm fixed-price contract, which carries no set-aside designation, involves the delivery of chemical-biological study services to be performed at the awardee's facility in Emigration Canyon, Utah. The National Cancer Institute, part of the National Institutes of Health, funds research and clinical initiatives related to cancer prevention, detection, and treatment, making this award consistent with Myriad's specialized focus on genetic testing and molecular diagnostics relevant to cancer risk assessment and disease management.
This delivery order represents a discrete procurement action within Myriad Genetic Laboratories' broader federal contracting portfolio, which has traditionally concentrated on providing Prolaris prostate cancer testing services to the Department of Veterans Affairs across multiple Veterans Integrated Service Networks. The award demonstrates the company's established capability in delivering genomic and chemical-biological services to federal healthcare agencies and reflects Myriad's expansion beyond its primary VA relationships to include engagement with civilian research and healthcare entities under the National Cancer Institute.
Quick answers
Who was awarded contract HHSN26100002?
HHSN26100002 was awarded to Myriad Genetic Laboratories Inc. by National Cancer Institute (National Institutes of Health) on June 25, 2007.
How much is contract HHSN26100002 worth?
The government has obligated $30,000 on HHSN26100002.
Is contract HHSN26100002 an order under another contract?
Yes. HHSN26100002 is a delivery order under HHSN263200400061816I, an indefinite delivery contract.
Was contract HHSN26100002 competed?
The extent of competition for HHSN26100002 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award